Viking Therapeutics (VKTX) released new clinical trial data on Sunday for its experimental weight-loss drugs, which include a highly anticipated oral pill. The San Diego-based company’s stock ...
As the popularity of GLP-1 meds like Wegovy and Zepbound grows, fewer Americans are turning to weight-loss surgeries to trim their waistlines, a new report finds.
Researchers at the University of Copenhagen have developed a new weight-loss drug that may surpass the effectiveness of Ozempic. This new drug stimulates calorie burning and reduces appetite ...
Scientists from the University of Copenhagen say they have developed a drug that decreases appetite ... suppressing appetite and stimulating weight loss. Nausea is a commonly reported side effect.